Breaking the Gut-Liver Axis: Breakthrough Experimental Drug Reverses Severe Fatty Liver Disease
Comments Off on Breaking the Gut-Liver Axis: Breakthrough Experimental Drug Reverses Severe Fatty Liver Disease
July 11, 2026
In a significant advancement for hepatology and metabolic medicine, researchers at Michigan Medicine have unveiled a promising new therapeutic strategy to combat metabolic dysfunction-associated steatohepatitis (MASH). A study published in The Journal of…
